The investigation of urinary podocytes from FSGS patients carrying either the G0/G0 or G1/G2 allele suggested that the APOL1 risk variants cause mitochondrial dysfunction linked with lipid accumulation and compensatory OXPHOS complexes elevation in podocytes (30). The gene discussed is APOL1; the disease is focal segmental glomerulosclerosis.